Study: More UC patients avoid colectomy with infliximab

07/8/2013 | Medscape (free registration)

Study data showed 84% of patients with steroid-refractory acute ulcerative colitis who took infliximab avoided colectomy during their admission, compared with 56% of patients given cyclosporine, Australian researchers report. At three and 12 months, the infliximab group continued to be significantly less likely to be treated with colectomy. Data showed patients given cyclosporine had slightly greater rates of additional immunosuppression at 12 months, compared with those taking infliximab.

View Full Article in:

Medscape (free registration)

Published in Brief: